Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation
Crossref DOI link: https://doi.org/10.1007/s11255-014-0792-0
Published Online: 2014-07-31
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Marques, Igor Denizarde Bacelar
Ramalho, Janaina
David, DaĆsa Ribeiro
Nahas, William Carlos
David-Neto, Elias
Text and Data Mining valid from 2014-07-31